1 – 10 of 89
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex
(
- Contribution to journal › Article
-
Mark
Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
(
- Contribution to journal › Article
- 2020
-
Mark
Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A : Interim analysis from the LEOPOLD Kids extension study
(
- Contribution to journal › Article
- 2017
-
Mark
Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments
(
- Contribution to journal › Article
- 2016
-
Mark
Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: A population-based cohort study.
(
- Contribution to journal › Article
- 2015
-
Mark
INR variability and outcomes in patients with mechanical heart valve prosthesis.
(
- Contribution to journal › Article
-
Mark
Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.
(
- Contribution to journal › Article
-
Mark
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
(
- Contribution to journal › Article
-
Mark
Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden.
(
- Contribution to journal › Article
-
Mark
Warfarin treatment complications do not correlate to cTTR when above 70.
(
- Contribution to journal › Article